Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152229 · ClinicalTrials.gov registry record
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
A clinical trial, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 300
- Enrollment target
NCT01152229: Completed study, sponsored by Medstar Health Research Institute.
NCT01152229 is a clinical trial that has completed, run by Medstar Health Research Institute. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01152229 has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.
Primary Outcome
Level of platelet reactivity as assessed with the Chrono-Log Lumi-Aggregometer, which measures levels of light transmittance after stimulation with ADP to estimate levels of platelet aggregation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-07 |
What the finished NCT01152229 record still lists
NCT01152229 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01152229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01152229 about?
NCT01152229 is a clinical study titled "Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine". The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize ...
What is the current status of trial NCT01152229?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2010-04. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01152229?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia